NCT06761430View on ClinicalTrials.gov

Evaluation of ClearPlasma in Patients With Upper Gastrointestinal Bleeding.

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

February 4, 2021

Study Completion Date

March 20, 2021

Conditions
Upper Gastrointestinal Bleeding (UGIB)
Interventions
DEVICE

ClearPlasma

ClearPlasmais an extra-corporeal plasma filtration device, designed to specifically extract plasminogen, a protein that drives fibrinolysis, from up to 250 mL of plasma. ClearPlasmaTM is a non-pyrogenic, sterile, single-use medical device.

Trial Locations (1)

Unknown

Area Medicina D'Urgenza e Pronto Soccorso Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore Largo A. Gemelli, 800168 -, Rome

All Listed Sponsors
lead

PlasFree Ltd.

INDUSTRY

NCT06761430 - Evaluation of ClearPlasma in Patients With Upper Gastrointestinal Bleeding. | Biotech Hunter | Biotech Hunter